1369406-03-0

Basic information

• Product Name: C₄₂H₄₁ClF₂O₆
• Synonyms: C₄₂H₄₁ClF₂O₆
• CAS NO: 1369406-03-0
• Molecular Weight: 715.234
• Mol File: 1369406-03-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₄₂H₄₁ClF₂O₆(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₂H₄₁ClF₂O₆(1369406-03-0)
• EPA Substance Registry System: C₄₂H₄₁ClF₂O₆(1369406-03-0)

Safety Data

• Hazardous Substances Data: 1369406-03-0(Hazardous Substances Data)

Upstream product

• 634181-78-5 (R)-4-((R)-1-(benzyloxy)-2,2-difluorobut-3-en-1-yl)-2,2-dimethyl-1,3-dioxolane 
• 1369405-70-8 (2R,3R)-3-(benzyloxy)-1-((tert-butyldimethylsilyl)oxy)-4,4-difluorohex-5-en-2-ol 
• 1369405-79-7 (2S,3R,5R)-2,3,6-tris(benzyloxy)-4,4-difluorohexane-1,5-diol 
• 1369405-77-5 (2R,4R,5S)-1,4,5-tris(benzyloxy)-6-((tert-butyldimethylsilyl)oxy)-3,3-difluorohexan-2-ol 
• 1369405-76-4 C₂₆H₃₈F₂O₅Si 
• 1369405-75-3 (((2S,3R)-2,3-bis(benzyloxy)-4,4-difluorohex-5-en-1-yl)oxy)(tert-butyl)dimethylsilane 
• 1369405-74-2 (2S,3R)-3-(benzyloxy)-1-((tert-butyldimethylsilyl)oxy)-4,4-difluorohex-5-en-2-ol 
• 1369405-72-0 (2S,3R)-3-(benzyloxy)-4,4-difluorohex-5-ene-1,2-diyl diacetate 
• 1369405-71-9 (S)-2-((R)-1-(benzyloxy)-2,2-difluorobut-3-en-1-yl)oxirane 
• 1005768-69-3 (2R,3R)-3-O-benzyl-4,4-difluoro-5-hexene-1,2,3-triol 
• 461432-23-5 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene 
• 1369405-80-0 (3R,4R,6R)-3,4-bis(benzyloxy)-6-((benzyloxy)methyl)-5,5-difluorotetrahydro-2H-pyran-2-one 

Downstream Products

• 1181680-69-2 (2R,4R,5S,6S)-4,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,3-difluorotetrahydro-2H-pyran 
• 1181680-71-6 (2S,3R,4R,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5,5-difluoro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol 

Relevant articles and documents

Synthesis and biological evaluation of SGLT2 inhibitors: Gem-difluoromethylenated Dapagliflozin analogs

Dapagliflozin is currently the most advanced SGLT2 inhibitor, which has been used in Phase III clinical trials for treatment of diabetes. Here we describe the design and synthesis of Dapagliflozin analogs modified with gem-difluoromethylene group. Their b